APOE and Alzheimer disease: This clearance route is likely deficient in APOE4 carriers, as shown by the co-localization of APOE and non-fibrillar Aβ in the perivascular space and neuropil surrounding cerebral arteries of human AD brains [82] and also preclinical transgenic models of amyloidosis on the human APOE background [81, 83–86].